Ncardia B.V.

Ncardia B.V. is a human induced pluripotent stem cell (iPSC) products and contract research organization provider supporting drug discovery and development. It offers iPSC-derived cell models, screening assays, and custom services for applications including disease modeling, safety pharmacology, CNS research, cardiac safety, and immuno-oncology safety assessment. Its portfolio includes neuronal and cardiomyocyte models designed for research use.